Noevir Holdings Co (TSE:4928) Other Operating Expense : 円31,544 Mil (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Noevir Holdings Co Other Operating Expense?

Noevir Holdings Co's Other Operating Expense for the three months ended in Mar. 2024 was 円7,494 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was 円31,544 Mil.

Noevir Holdings Co's quarterly Other Operating Expense increased from Sep. 2023 (円7,940 Mil) to Dec. 2023 (円8,030 Mil) but then declined from Dec. 2023 (円8,030 Mil) to Mar. 2024 (円7,494 Mil).

Noevir Holdings Co's annual Other Operating Expense increased from Sep. 2021 (円19,722 Mil) to Sep. 2022 (円20,917 Mil) but then declined from Sep. 2022 (円20,917 Mil) to Sep. 2023 (円20,846 Mil).

Noevir Holdings Co Other Operating Expense Historical Data

The historical data trend for Noevir Holdings Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noevir Holdings Co Other Operating Expense Chart

Noevir Holdings Co Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Other Operating Expense

Get a 7-Day Free Trial

19,178.00

18,750.00

19,722.00

20,917.00

20,846.00

Noevir Holdings Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															7,476.00	8,080.00	7,940.00	8,030.00	7,494.00

Noevir Holdings Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円31,544 Mil.

Noevir Holdings Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Noevir Holdings Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Noevir Holdings Co (TSE:4928) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Noevir Holdings Co Ltd (TSE:4928) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

6-13-1 Minatojimanakamachi, Chuo-ku, Kobe, JPN, 650-8521

Website

http://www.noevirholdings.co.jp

Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses, cosmetics, and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces and sells a broad range of products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in a number of countries across the world, and focuses on developing Asian markets.

Noevir Holdings Co (TSE:4928) Headlines

No Headlines